Rights Issue7 Aug 2026, 04:53 pm
Jainex Aamcol: CARE Ratings Reports No Deviation in Rights Issue Proceeds
AI Summary
Jainex Aamcol Ltd has received a Monitoring Agency Report from CARE Ratings Limited for the quarter ended June 30, 2026. The report confirms no deviation in the utilization of the ₹8.98 crore raised through its Rights Issue. While there was a slight delay in utilizing funds for the expansion program, the timeline was revised with board approval. Surplus funds initially earmarked for issue expenses were reallocated to the expansion program as per board resolutions. The report also notes that unsecured loans were adjusted against subscription amounts, not received in cash.
Key Highlights
- CARE Ratings confirms no deviation in rights issue proceeds utilization.
- Rights issue amount aggregated to ₹8.98 crore.
- Minor delay in expansion fund utilization, timeline revised.
- Surplus issue expenses reallocated to expansion program.
- Unsecured loans adjusted against subscription amounts.
Price Impact
More from JAINEX